BCSS Bain Cap GSS CEO prioritizes expansion of alternative asset offerings to drive longterm revenue growth IRS AI Enforcement Deployment and Audit Rate Outlook STOK Stoke Therapeutics Q4 2025 EPS misses estimates by 333 pushing shares 258 lower in todays session